Tel: 01789 267520

SMA Drug Pipeline

Using this drug pipeline, we are tracking the development of all possible SMA treatments currently being tested in human clinical trials.

The diagram is split into:

  • drugs that do not affect SMN protein levels (SMN-independent)
  • drugs that increase SMN protein levels (SMN-dependent).

The diagram will be regularly updated to map the development and progress of each drug programme.

Download the diagram

Last updated June 2018